Videos
Advantages and Potential of MR Fingerprinting in Epilepsy, Neurology: Irene Wang, PhD
January 18th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed opportunities for MR fingerprinting to expand, both in the epilepsy field and in general neurology. [WATCH TIME 3 minutes]
Considering Cognitive Behavioral Therapy for Insomnia
Expert perspectives on the benefits of and limitations to cognitive behavioral therapy for insomnia.
Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD
January 16th 2022The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]
Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD
January 14th 2022The clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]
The Changing Landscape of Preventative Migraine Treatments
A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Disorders of Consciousness and COVID-19: David Fischer, MD
January 14th 2022The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital discussed findings from a recent study that evaluated patients with COVID-19 and disorders of consciousness. [WATCH TIME: 3 minutes]
Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD
January 13th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided insight on her study presented at AES 2021, which showed that MR fingerprinting can differentiate focal cortical dysplasia from healthy tissue. [WATCH TIME: 4 minutes]
Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD
January 13th 2022Outlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]
SAGE and BrainTest for Cognitive Assessment and Clinical Trial Enrollment: Douglas Scharre, MD
January 12th 2022The director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center discussed benefits of both the pen-and-paper and digital assessments. [WATCH TIME: 7 minutes]
Clinical Experience as a Factor in the Inconsistencies of Migraine Care: Anne-Maree Kelly, MD
January 12th 2022The director of the Joseph Epstein Center for Emergency Medicine Research discussed whether years of experience causes variation in the way migraine is diagnosed and treated in an emergency department setting. [WATCH TIME: 2 minutes]
Development of SAGE for Early Dementia Detection: Douglas Scharre, MD
January 11th 2022The director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center discussed motivations behind creating the pen-and-paper test, as well as its digital companion. [WATCH TIME: 2 minutes]
Next Steps in Understanding Cognitive Decline in Aging MS: Dejan Jakimovski, MD, PhD
January 11th 2022The research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 4 minutes]
Information Sharing, Collaboration in MS Care Amidst the COVID-19 Pandemic: Mitzi Joi Williams, MD
January 9th 2022Discussing the willingness to share data during the pandemic, the founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center spoke to the positive effect of collaboration in the MS field. [WATCH TIME: 2 minutes]
Addressing Health Disparities in the US Following COVID-19: Mitzi Joi Williams, MD
January 7th 2022The founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center commented on the effect of the pandemic on needs for underrepresented populations in the multiple sclerosis space, as well as the pros and cons of telehealth. [WATCH TIME: 3 minutes]
Headache Specialists for Preventative Migraine Treatments
A discussion on when a patient should be referred to a headache specialist for preventive migraine treatment.
Preventative Migraine Therapies: The ADVANCE Trial and the Future
Jessica Ailani, MD, details how the phase 3 ADVANCE trial will shape the research of future agents for preventive migraine treatment.
Monoclonal Antibodies in Development for Alzheimer Disease: Anton Porsteinsson, MD
January 7th 2022The director of the Alzheimer's Disease Care, Research and Education Program at the University of Rochester offered an extensive overview of 3 monoclonal antibodies in development for Alzheimer disease. [WATCH TIME: 9 minutes]
